Innogenetics achieves CE mark for new human papillomavirus (HPV) genotyping test
The INNO-LiPA HPV Genotyping Extra is designed for the identification of 28 different genotypes. The test encompasses 18 high-risk genotypes, including genotypes 16, and 18; 7 low-risk genotypes, including genotypes 6 and 11; and 3 additional genotypes. The useful information provided by the INNO-LiPA HPV Genotyping Extra can thereby serve as an important complement to Pap smear testing, and current DNA-based HPV screening tests. Automation is available, allowing the simultaneous processing of up to 48 different patient samples. Results are available within 3 hours.
Innogenetics will initially commercialize the product throughout Europe, where the product will be sold through its own specialized sales force. The INNO-LiPA HPV Genotyping Extra kit is anticipated to add to Innogenetics' revenues as of this quarter.
Most read news
Other news from the department research and development
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.